Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029)
Clinical trial NCT00474617 · COMPLETED
Trial details
- NCT number
- NCT00474617
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-29
- Primary completion
- 2006-10-20
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.